NBIXNEUROCRINE BIOSCIENCES INC

medium
Health Care·Drug Manufacturers - Specialty & Generic·public
Risk Score0.73
Low RiskCritical
Predictions
2
Signals
5
Severity
MEDIUM
Freshest Signal
0d ago

Active Predictions

Earnings Surprise Likelymedium0.73

NEUROCRINE BIOSCIENCES INC shows elevated signs of likely earnings surprise based on sentiment in the past 24 hours. Analyst rating momentum (bearish): 23 downgrades in 90d, downgrade ratio 5%, 26 upgrades. Key Drivers: [STRONG] Sentiment: analyst rating momentum detected — analyst rating momentum (bearish): 23 downgrades in 90d, downgrade ratio 5%, 26 upgrades. (1 signal, today, 78%) [MODERATE] Price Action: volatility compression (BB squeeze) detected — volatility compression: bb width at

moderate_signal·negative·earnings
Layoff Possiblelow0.49

NEUROCRINE BIOSCIENCES INC shows early signs of possible workforce restructuring based on sentiment in the past 24 hours. Analyst rating momentum (bearish): 23 downgrades in 90d, downgrade ratio 5%, 26 upgrades. Key Drivers: [STRONG] Sentiment: analyst rating momentum detected — analyst rating momentum (bearish): 23 downgrades in 90d, downgrade ratio 5%, 26 upgrades. (1 signal, today, 100%) [WEAK] Market Signals: activist ownership detected detected — activist ownership detected: 0 sc 13d f

moderate_signal·negative·layoffs

Signal Sources

Media SentimentSec DisclosurePrice Action

Get full analysis for NBIX

Sign up free to see detailed signal breakdowns, set alerts, add to watchlists, and compare with sector peers.

Sign Up Free

More in Health Care

Unveila provides intelligence for research purposes. Predictions are probability-weighted estimates, not investment advice. Past accuracy does not guarantee future results.

NBIX Risk Analysis — NEUROCRINE BIOSCIENCES INC | Unveila | Unveila